1. Global Cancer Incidence and Mortality Rates and Trends—An Update
   Lindsey A. Torre et al, 2016, Cancer Epidemiology, Biomarkers & Prevention CrossRef
2. Global cancer statistics, 2012
   Lindsey A. Torre et al, 2015, CA: A Cancer Journal for Clinicians CrossRef
3. Intracrinology-revisited and prostate cancer
   Trevor M. Penning et al, 2020, The Journal of Steroid Biochemistry and Molecular Biology CrossRef
4. Post-finasteride syndrome – does it really exist?
   Radosław B. Maksym et al, 2019, The Aging Male CrossRef
5. Delivery of a TNF‐α–derived peptide by nanoparticles enhances its antitumor activity by inducing cell‐cycle arrest and caspase‐dependent apoptosis
   Qiuxia Yan et al, 2018, The FASEB Journal CrossRef
6. Probiotics: a proactive approach to health. A symposium report
   Linda V. Thomas et al, 2015, British Journal of Nutrition CrossRef
7. Risks and side effects in the medical management of benign prostatic hyperplasia
   Abdulghafour Halawani et al, 2023, Prostate International CrossRef
8. Finasteride
   Konstantinos Anastassakis, 2022, Androgenetic Alopecia From A to Z CrossRef
9. Moving Beyond the Androgen Receptor (AR): Targeting AR-Interacting Proteins to Treat Prostate Cancer
   Christopher Foley et al, 2016, Hormones and Cancer CrossRef
10. Prostate Cancer Prevention: Concepts and Clinical Trials
    Zachary Hamilton et al, 2016, Current Urology Reports CrossRef
11. Impact of 5α‐reductase inhibitor and α‐blocker therapy for benign prostatic hyperplasia on prostate cancer incidence and mortality
    Maria I. Van Rompay et al, 2019, BJU International CrossRef
12. Melatonin—A New Prospect in Prostate and Breast Cancer Management
    Comfort Anim-Koranteng et al, 2021, Cureus CrossRef
13. Dutasteride
    Konstantinos Anastassakis, 2022, Androgenetic Alopecia From A to Z CrossRef
14. Re: Incidence of Prostate Cancer in Hypogonadal Men Receiving Testosterone Therapy: Observations from 5-Year Median Followup of 3 Registries
    Peter Butler et al, 2015, European Urology CrossRef
15. LXRs, SHP, and FXR in Prostate Cancer: Enemies or Ménage à Quatre With AR?
    Marica Cariello et al, 2018, Nuclear Receptor Signaling CrossRef
16. Impact of 5α-Reductase Inhibitors on Disease Reclassification among Men on Active Surveillance for Localized Prostate Cancer with Favorable Features
    Charles Dai et al, 2018, Journal of Urology CrossRef
17. Applying mass spectrometric methods to study androgen biosynthesis and metabolism in prostate cancer
    Matias Knuuttila et al, 2019, Journal of Molecular Endocrinology CrossRef